US Bancorp’s Titan Medical Inc. Ordinary Shares TMDI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-500
Closed -$330 4241
2022
Q4
$330 Sell
500
-111
-18% -$58 ﹤0.01% 4037
2022
Q3
$0 Hold
611
﹤0.01% 4285
2022
Q2
$0 Hold
611
﹤0.01% 4304
2022
Q1
$0 Hold
611
﹤0.01% 4267
2021
Q4
$0 Hold
611
﹤0.01% 4275
2021
Q3
$1K Hold
611
﹤0.01% 4047
2021
Q2
$1K Hold
611
﹤0.01% 3969
2021
Q1
$1K Buy
611
+111
+22% +$248 ﹤0.01% 3853
2020
Q4
$1K Hold
500
﹤0.01% 3732
2020
Q3
$0 Hold
500
﹤0.01% 3907
2020
Q2
$0 Hold
500
﹤0.01% 3935
2020
Q1
$0 Hold
500
﹤0.01% 3851
2019
Q4
$0 Hold
500
﹤0.01% 3765
2019
Q3
$1K Hold
500
﹤0.01% 3537
2019
Q2
$1K Hold
500
﹤0.01% 3584
2019
Q1
$1K Hold
500
﹤0.01% 3544
2018
Q4
$1K Hold
500
﹤0.01% 3544
2018
Q3
$1K Hold
500
﹤0.01% 3598
2018
Q2
$3K Buy
+500
New +$3K ﹤0.01% 3452

Other funds holding TMDI

US Bancorp's TMDI Position: Q1 2023 in Review

US Bancorp sold out of Titan Medical Inc. Ordinary Shares (TMDI) in Q1 2023, closing a stake of 500 shares — an estimated $330 sold.

US Bancorp first reported a position in TMDI in Q2 2018 and held it in 19 quarters. The position peaked at $3K in Q2 2018. 12 funds tracked by Wall St. Rank hold TMDI as of Q1 2023.

  • US Bancorp reported no remaining Titan Medical Inc. Ordinary Shares position as of Q1 2023 after selling out during the quarter.
  • US Bancorp sold 500 Titan Medical Inc. Ordinary Shares shares in Q1 2023, an estimated $330.
  • US Bancorp first reported a position in Titan Medical Inc. Ordinary Shares in Q2 2018 and held it in 19 quarters.
  • US Bancorp's Titan Medical Inc. Ordinary Shares position peaked at $3K in Q2 2018.
  • 12 funds tracked by Wall St. Rank held Titan Medical Inc. Ordinary Shares as of Q1 2023.

Based on US Bancorp's 13F filing for Q1 2023, filed 9 May 2023.